Anti-SPAST monoclonal antibody

Pre-made anti-SPAST monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SPAST/SPAST products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1794-Ab-1/ GM-Tg-hg-IP1794-Ab-2Anti-Human SPAST monoclonal antibodyHuman
GM-Tg-rg-IP1794-Ab-1/ GM-Tg-rg-IP1794-Ab-2Anti-Rat SPAST monoclonal antibodyRat
GM-Tg-mg-IP1794-Ab-1/ GM-Tg-mg-IP1794-Ab-2Anti-Mouse SPAST monoclonal antibodyMouse
GM-Tg-cynog-IP1794-Ab-1/ GM-Tg-cynog-IP1794-Ab-2Anti-Cynomolgus/ Rhesus macaque SPAST monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1794-Ab-1/ GM-Tg-felg-IP1794-Ab-2Anti-Feline SPAST monoclonal antibodyFeline
GM-Tg-cang-IP1794-Ab-1/ GM-Tg-cang-IP1794-Ab-2Anti-Canine SPAST monoclonal antibodyCanine
GM-Tg-bovg-IP1794-Ab-1/ GM-Tg-bovg-IP1794-Ab-2Anti-Bovine SPAST monoclonal antibodyBovine
GM-Tg-equg-IP1794-Ab-1/ GM-Tg-equg-IP1794-Ab-2Anti-Equine SPAST monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1794-Ab-1/ GM-Tg-hg-IP1794-Ab-2; GM-Tg-rg-IP1794-Ab-1/ GM-Tg-rg-IP1794-Ab-2;
GM-Tg-mg-IP1794-Ab-1/ GM-Tg-mg-IP1794-Ab-2; GM-Tg-cynog-IP1794-Ab-1/ GM-Tg-cynog-IP1794-Ab-2;
GM-Tg-felg-IP1794-Ab-1/ GM-Tg-felg-IP1794-Ab-2; GM-Tg-cang-IP1794-Ab-1/ GM-Tg-cang-IP1794-Ab-2;
GM-Tg-bovg-IP1794-Ab-1/ GM-Tg-bovg-IP1794-Ab-2; GM-Tg-equg-IP1794-Ab-1/ GM-Tg-equg-IP1794-Ab-2
Products NameAnti-SPAST monoclonal antibody
Formatmab
Target NameSPAST
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SPAST monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1794-Ag-1Recombinant multi-species SPAST/ ADPSP/ FSP2 protein


    Target information

    Target IDGM-IP1794
    Target NameSPAST
    Gene ID6683,50850,362700,706264,608582,101088156,521442,100054514
    Gene Symbol and SynonymsADPSP,FSP2,mKIAA1083,SPAST,SPG4
    Uniprot AccessionQ9UBP0,B2RYN7,A2VDN5
    Uniprot Entry NameSPAST_HUMAN,SPAST_RAT,SPAST_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseIgA glomerulonephritis
    Gene EnsemblENSG00000021574
    Target ClassificationN/A

    The target: SPAST, gene name: SPAST, also named as ADPSP, FSP2, SPG4. This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.